Preview

Obstetrics, Gynecology and Reproduction

Advanced search

MAGNESIUM DEFICIENCY IN OBSTETRICS AND GYNECOLOGY

Full Text:

Abstract

Biological role of magnesium in the human body is proved and very well-known. The pathogenesis of obstetrics and gynecology pathology shows that, next to magnesium, pyridoxine plays a key role. An effective strategy for prevention premature delivery, preeclampsia and eclampsia is proved to be timely magnesium sulfate application. We also have facts about its neuroprotective effect on the fetus. However the possibility of overdosage and serious side effects lead to a restricted usage of magnesium sulfate. To minimize the risk of overdosage, its necessary to follow the standard protocols, to make independent crosscheck and to monitor the condition of the patient. Its also reasonable to take magnesium sulfateorally - apart from better bioavailability,overdosage won’t cause serious side effects. Organic magnesium sulfate for magnesium deficiency control and associated symptoms is also justified for premenstrual syndrome (PMS), when COC (Combined Oral Contraceptives) and HRT (hormonal replacement therapy) is prescribed for women undergoing menopause. Magnesium citrate is more preferable because citrate-anion facilitates high bioavailability of magnesium, its also necessary in Krebs cycle and it turns into carbon dioxide and water. Due to this citrate is a perfect transporter of magnesium to the cells.

About the Author

C. Dadak
Department of Gynecology and Obstetrics, Department of basic and advanced international postgraduate education, Medical University of Vienna (Austria)
Austria


References

1. Spätling L., Spätling G. Magnesium supplementation in pregnancy. A double-blind study. Br. J. Obstet. Gynaecol. 1988; 95 (2): 120-125.

2. Di Micco P., D'uva M., Strina I., De Placido G., Di Fiore R., Quaranta S., Castaldo G. Recurrent pregnancy loss and thrombophilia. Clin. Lab. 2007; 53 (5-6): 309-314.

3. Tooher R., Gates S., Dowswell T., Davis L.J. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database of Systematic Reviews. 2010; Issue 5. Art. No.: CD001689. DOI: 10.1002/14651858.CD001689. pub 2.

4. WHO recommended definitions, terminology and format for statistical tables related to perinatal period and use of a new certificate for cause of perinatal deaths. Acta Obstet. Gynecol. Scand. 1977; 56 (3): 247-253.

5. Mercer B.M., Goldenberg R.L., Moawad A.H. et al. The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am. J. Obstet. Gynecol. 1999; 181: 1216-1221.

6. Jackson R.A., Gibson K.A., Wu Y.W. et al. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet. And Gynecol. 2004; 104 (2): 551-563.

7. Блинов Д.В. Объективные методы определения тяжести и прогноза перинатального гипоксически-ишемического поражения ЦНС. Акушерство, гинекология и репродукция. 2011; 2: 5-12.

8. Leitich H., Brumbauer M., Kaider A. et al. Cervical length and dilation of the internal as detected by vaginal ultrasonography as markers for preterm delivery: a systematic review. Am. J. Obstet. Gynecol. 1999; 181: 1465-1472.

9. Crowther C.A., Hiller J.E., Doyle L.W. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database of Systematic Reviews. 2002; Issue 4. Art. No.: CD001060. DOI: 10.1002/14651858.CD001060.

10. Mercer B.M., Merlino A.A. Magnesium sulfate for preterm labor and preterm birth. Obstet. Gynecol. 2009; 114 (3): 650-668.

11. Doyle L.W., Crowther C.A., Middleton P., Marret S., Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database of Systematic Reviews. 2009; Issue 1. Art. No.: CD004661. DOI: 10.1002/14651858.CD004661.pub 3.

12. Crowther C.A., Hiller J.E., Doyle L.W., Haslam R.R. Australasian Collaborative Trial of Magnesium Sulphate (ACTOMg SO4) Collaborative Group. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA. 2003; 290 (20): 2669-2676.

13. Rouse D.J., Hirtz D.G., Thom E., Varner M.W., Spong C.Y., Mercer B.M., Iams J.D., Wapner R.J., Sorokin Y., Alexander J.M., Harper M., Thorp J.M. Jr., Ramin S.M., Malone F.D., Carpenter M., Miodovnik M., Moawad A., O'Sullivan M.J., Peaceman A.M., Hankins G.D., Langer O., Caritis S.N., Roberts J.M.; Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N. Engl. J. Med. 2008; 359 (9): 895-905.

14. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am. J. Obstet. Gynecol. 2000; 183: 1-22.

15. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. World Health Organization, Dept. of Reproductive Health and Research, Dept. of Maternal, Newborn, Child and Adolescent Health, Dept. of Nutrition for Health and Development. 2011; 38 p.

16. Duley L., Gülmezoglu A.M., Chou D. Magnesium sulphate versus lytic cocktail for eclampsia. Cochrane Database Syst Rev. 2010; 9: CD002960. DOI: 10.1002/14651858. CD002960.pub 2.

17. Medication Errors in Labor and Delivery: Reducing Maternal and Fetal Harm. Pa Patient Saf. Advis. 2009; 16 (6) (Suppl. 1): 1-6.

18. Higdon J. An Evidence-Based Approach to Vitamins and minerals. New York-Stuttgart. 2005.

19. Ranade V.V., Somberg J.C. Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans. Am. J. Ther. 2001; 8 (5): 345-357.

20. Sriboonlue P., Jaipakdee S., Jirakulsomchok D., Mairiang E., Tosukhowong P., Prasongwatana V., Savok S. Changes in erythrocyte contents of potassium, sodium and magnesium and Na, K-pump activity after the administration of potassium and magnesium salts. J. Med. Assoc. Thai. 2004; 87 (12): 1506-1512.


For citation:


Dadak C. MAGNESIUM DEFICIENCY IN OBSTETRICS AND GYNECOLOGY. Obstetrics, Gynecology and Reproduction. 2013;7(2):6-14. (In Russ.)

Views: 199


ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)